Koyama Masayuki, Himuro Nobuaki, Nakata Kei, Oyatani Keisuke, Shinohara Yukiko, Ohnishi Hirofumi, Arima Hisatomi
Division of Public Health, Department of Social Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Hypertens Res. 2025 Jul 29. doi: 10.1038/s41440-025-02260-6.
Hypertension affects more than 4 billion people worldwide and is a major risk factor for cardiovascular disease. Improving physical activity is an effective way to manage hypertension, and there has been a lot of interest in the use of wearable devices for promoting physical activity, which have become increasingly popular in recent years, but in many countries, improvements in physical activity levels remain inadequate. This systematic review and meta-analysis investigated whether interventions using wearable devices have a beneficial effect on blood pressure in adults. Following PRISMA 2020 guidelines and registered with PROSPERO (CRD42023442506), we searched PubMed, MEDLINE, Cochrane Library, and IchuShi-Web, identifying 21 randomized controlled trials including participants with hypertension, type 2 diabetes, or overweight/obesity. Interventions ranged from 12 to 48 weeks using pedometers, activity trackers, and smartwatches. Random-effects meta-analysis showed these interventions did not produce statistically significant improvements in systolic or diastolic blood pressure at any intervention duration (12, 24, or 48 weeks). Similarly, no statistically significant improvements were found in secondary outcomes (body weight, fasting blood glucose, and Hemoglobin A1c). Heterogeneity varied from low to high depending on outcome and intervention period. These findings indicate that evidence of direct intervention using wearable devices for promoting physical activity alone is currently insufficient to establish clinically meaningful improvements in blood pressure and related metabolic parameters. Future research may need to integrate wearable technology into comprehensive care models that combine targeted feedback and education with behavioral support strategies, rather than direct intervention through monitoring alone.
高血压影响着全球超过40亿人,是心血管疾病的主要风险因素。增加身体活动是控制高血压的有效方法,近年来,人们对使用可穿戴设备来促进身体活动产生了浓厚兴趣,这类设备也越来越受欢迎,但在许多国家,身体活动水平的改善仍然不足。本系统评价和荟萃分析调查了使用可穿戴设备的干预措施对成年人血压是否有有益影响。遵循PRISMA 2020指南并在PROSPERO(CRD42023442506)注册,我们检索了PubMed、MEDLINE、Cochrane图书馆和IchuShi-Web,确定了21项随机对照试验,参与者包括高血压、2型糖尿病或超重/肥胖患者。干预措施使用计步器、活动追踪器和智能手表,持续时间从12周到48周不等。随机效应荟萃分析表明,在任何干预持续时间(12周、24周或48周),这些干预措施均未在收缩压或舒张压上产生具有统计学意义的改善。同样,在次要结局(体重、空腹血糖和糖化血红蛋白)方面也未发现具有统计学意义的改善。异质性根据结局和干预期从低到高不等。这些发现表明,目前仅使用可穿戴设备促进身体活动的直接干预证据不足以在血压和相关代谢参数方面实现具有临床意义的改善。未来的研究可能需要将可穿戴技术整合到综合护理模式中,该模式将有针对性的反馈和教育与行为支持策略相结合,而不是仅通过监测进行直接干预。